Photo

Photo detail

Stories this photo appears in:

Celladon Corp. Suspends All R&D Activities

Celladon Corp. announced that it will suspend all research and development activities.

Tease photo

Celladon Suspending R&D Activities

Celladon Corp. announced that it will suspend all research and development activities.

Tease photo

Celladon Announces Closing of Public Offering of Common Stock

Celladon Corp., a San Diego-based biotech company, has announced the closing of its underwritten public offering of 4,600,000 shares of its common stock at $9.50 per share.

Tease photo

Celladon IPO Aims to Raise $40 Million

Celladon Corp. plans to raise $40 million by offering 5 million shares at $8 per share in its upcoming IPO, according to Renaissance Capital.

Tease photo